Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 7/2015

01-07-2015 | Stanford Multidisciplinary Seminars

Acute Liver Failure: A Potential Complication of Antithyroid Medication Use

Authors: Christina Chou, Robert J. Wong, John P. Higgins, Ryan B. Perumpail, Aijaz Ahmed

Published in: Digestive Diseases and Sciences | Issue 7/2015

Login to get access

Excerpt

Drug-induced liver injury is one of the most common identifiable causes of acute liver failure in the USA. Although most examples of idiosyncratic drug hepatotoxicity usually occur within the first 6 months after drug initiation, hepatic injury can occur 1–2 years after starting therapy. Here, we present two patients with hyperthyroidism who developed acute liver failure secondary to antithyroid medication use. …
Literature
1.
Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the study of liver diseases position paper on acute liver failure 2011. Hepatology. 2012;55:965–967.PubMedCentralPubMedCrossRef
2.
Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10:1018–1023.PubMedCrossRef
3.
Livadas S, Xyrafis X, Economou F, et al. Liver failure due to antithyroid drugs: report of a case and literature review. Endocr. 2010;38:24–28.CrossRef
4.
Carrion AF, Czul F, Arosemena LR, et al. Propylthiouracil-induced acute liver failure: role of liver transplantation. Int J Endocrinol. 2010;2010:910636.PubMedCentralPubMedCrossRef
5.
Glinoer D, Cooper DS. The propylthiouracil dilemma. Curr Opin Endocrinol Diabetes Obes. 2012;19:402–407.PubMedCrossRef
6.
Benyounes M, Sempoux C, Daumerie C, Rahier J, Geubel AP. Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferase monitoring? World J Gastroenterol. 2006;12:6232–6234.PubMedCentralPubMed
Metadata
Title
Acute Liver Failure: A Potential Complication of Antithyroid Medication Use
Authors
Christina Chou
Robert J. Wong
John P. Higgins
Ryan B. Perumpail
Aijaz Ahmed
Publication date
01-07-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3389-7

Other articles of this Issue 7/2015

Digestive Diseases and Sciences 7/2015 Go to the issue

Review

Complementary and Alternative Medicine Use Is Prevalent Among Patients with Gastrointestinal Diseases

Original Article

Factors Associated with the Quality of Transient Elastography

Editorial

Tregs: A Therapeutic Target for the Treatment of Portal Fibrosis?

Original Article

Core 2 Mucin-Type O-Glycan Is Related to EPEC and EHEC O157:H7 Adherence to Human Colon Carcinoma HT-29 Epithelial Cells

Original Article

Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection

Original Article

Abdominal Fat Accumulation, as Measured by Computed Tomography, Increases the Risk of Ischemic Colitis: A Retrospective Case–Control Study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits